Novel Targets in Relapsed and Relapsed/Refractory Multiple MyelomaByNoa BiranApril 13th 2015Current approaches to the management of multiple myeloma (MM), in particular the introduction of proteasome inhibitors (PIs) and immunomodulatory agents (IMiDs), have improved the survival of patients.